Showing results (2421-2430 of 4,401) with videos related to

Sort By:
Pageof 441
ACS Medicinal Chemistry Letters|April 25, 2017
Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOXJohn H Hutchinson, Martin W Rowbottom, David Lonergan, et al.
ACS Medicinal Chemistry Letters|April 25, 2017
Integrated Platform for Expedited Synthesis-Purification-Testing of Small Molecule LibrariesAleksandra Baranczak, Noah P Tu, Jasmina Marjanovic, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Drug Discovery: Collaborations between Contract Research Organizations and the Pharmaceutical IndustryVictoria A Steadman
ACS Medicinal Chemistry Letters|July 24, 2018
H2O2/Peroxynitrite-Activated Hydroxamic Acid HDAC Inhibitor Prodrugs Show Antileukemic Activities against AML CellsYi Liao, Liping Xu, Siyu Ou, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone SkeletonYuko Nishiyama, Shuichi Mori, Makoto Makishima, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
In Search of Selectivity in Inhibition of ADAM10Kiran V Mahasenan, Derong Ding, Ming Gao, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Design, Synthesis, and Biological Evaluation of Allosteric Effectors That Enhance CO Release from CarboxyhemoglobinSara R Goldstein, Chen Liu, Martin K Safo, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Biocatalysis in the Pharmaceutical Industry: The Need for SpeedMatthew D Truppo
ACS Medicinal Chemistry Letters|May 20, 2017
Toward Resolving the Resveratrol Conundrum: Synthesis and in Vivo Pharmacokinetic Evaluation of BCP-ResveratrolYi Ling Goh, Yan Ting Cui, Vishal Pendharkar, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Development of Highly Affine and Selective Fluorinated Cannabinoid Type 2 Receptor LigandsRareş-Petru Moldovan, Kristin Hausmann, Winnie Deuther-Conrad, et al.
Pageof 441